Optimax Holdings Sdn Bhd - Asset Resilience Ratio

Latest as of September 2025: 13.92%

Optimax Holdings Sdn Bhd (0222) has an Asset Resilience Ratio of 13.92% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Optimax Holdings Sdn Bhd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

RM20.32 Million
≈ $5.10 Million USD Cash + Short-term Investments

Total Assets

RM146.00 Million
≈ $36.66 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Optimax Holdings Sdn Bhd's Asset Resilience Ratio has changed over time. See 0222 equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Optimax Holdings Sdn Bhd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Optimax Holdings Sdn Bhd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents RM19.30 Million 13.22%
Short-term Investments RM1.01 Million 0.69%
Total Liquid Assets RM20.32 Million 13.92%

Asset Resilience Insights

  • Moderate Liquidity: Optimax Holdings Sdn Bhd has 13.92% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Optimax Holdings Sdn Bhd Industry Peers by Asset Resilience Ratio

Compare Optimax Holdings Sdn Bhd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Max Healthcare Institute Limited
NSE:MAXHEALTH
Medical Care Facilities 0.58%
Extendicare Inc
TO:EXE
Medical Care Facilities 32.62%
MLP Saglik Hizmetleri AS
IS:MPARK
Medical Care Facilities 0.99%
Pacific Smiles Group Ltd
AU:PSQ
Medical Care Facilities 10.35%
Pihlajalinna Oy
HE:PIHLIS
Medical Care Facilities 5.13%
Ramsay Health Care Ltd
AU:RHC
Medical Care Facilities 3.49%
Regis Healthcare Ltd
AU:REG
Medical Care Facilities 2.29%
Oceania Healthcare Ltd
AU:OCA
Medical Care Facilities 0.01%

Annual Asset Resilience Ratio for Optimax Holdings Sdn Bhd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Optimax Holdings Sdn Bhd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.19% RM282.00K
≈ $70.80K
RM148.67 Million
≈ $37.33 Million
-2.34pp
2023-12-31 2.53% RM3.03 Million
≈ $761.49K
RM119.74 Million
≈ $30.06 Million
-2.32pp
2022-12-31 4.85% RM4.92 Million
≈ $1.23 Million
RM101.39 Million
≈ $25.45 Million
-0.15pp
2021-12-31 5.00% RM4.63 Million
≈ $1.16 Million
RM92.61 Million
≈ $23.25 Million
-25.92pp
2020-12-31 30.92% RM26.04 Million
≈ $6.54 Million
RM84.23 Million
≈ $21.15 Million
+16.88pp
2019-12-31 14.04% RM8.97 Million
≈ $2.25 Million
RM63.91 Million
≈ $16.05 Million
+4.19pp
2018-12-31 9.85% RM5.53 Million
≈ $1.39 Million
RM56.19 Million
≈ $14.11 Million
+1.90pp
2017-12-31 7.95% RM3.20 Million
≈ $803.92K
RM40.27 Million
≈ $10.11 Million
-0.69pp
2016-12-31 8.64% RM2.80 Million
≈ $703.24K
RM32.43 Million
≈ $8.14 Million
--
pp = percentage points

About Optimax Holdings Sdn Bhd

KLSE:0222 Malaysia Medical Care Facilities
Market Cap
$70.93 Million
RM282.52 Million MYR
Market Cap Rank
#20618 Global
#388 in Malaysia
Share Price
RM0.52
Change (1 day)
-0.95%
52-Week Range
RM0.50 - RM0.70
All Time High
RM0.82
About

Optimax Holdings Berhad, an investment holding company, engages in the provision of eye specialist services and related products in Malaysia. The company's specialist centers offer a range of treatments relating to eye diseases, such as cataracts, glaucoma, conjunctivitis, age-related macular degeneration, diabetic retinopathy, retinal detachment, pterygium, keratoconus, dry eyes, and other eye d… Read more